Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1102 | 1022 | 1102 | 1154 | 1234 | 1594 |
Fund Return | 10.24% | 2.23% | 10.24% | 4.89% | 4.3% | 4.77% |
Place in category | 50 | 100 | 50 | 12 | 16 | 4 |
% in Category | 6 | 11 | 6 | 2 | 3 | 1 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS Lux Bond SICAV Convert Global q | 4.34B | 5.18 | -1.54 | 4.24 | ||
UBS Lux Bond SICAV Convert Global E | 4.34B | 6.18 | -0.62 | 5.23 | ||
UBS Bond S Convert Global EUR F Acc | 4.35B | 5.59 | -1.15 | 4.76 | ||
UBS Bond S Convert Global EUR hedge | 4.34B | 6.18 | -0.61 | 5.23 | ||
UBS Bond S Convert Global EUR I A1 | 4.34B | 5.38 | -1.36 | 4.55 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Euro High Yield Class C EUR Cap | 3.22B | 7.13 | 2.60 | 3.67 | ||
Euro High Yield Class C EUR Dis | 3.22B | 7.06 | 2.54 | 3.59 | ||
Candriam Bonds Euro High Yield Clas | 3.3B | 7.08 | 2.51 | 3.56 | ||
Euro High Yield Class I EUR Cap | 3.22B | 7.92 | 3.08 | 4.06 | ||
Euro High Yield Class N EUR Cap | 3.22B | 6.80 | 2.24 | 3.29 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Teva Pharmaceutical Finance Netherlands II B.V 7.375% | XS2592804434 | 1.28 | - | - | |
LHMC Finco 2 S.a r.l. 7.25% | XS2059777594 | 0.96 | - | - | |
Germany 2.6 15-Aug-2034 | DE000BU2Z031 | 0.96 | 100.670 | -0.05% | |
CPI Property Group S.A. 4.875% | XS1982704824 | 0.95 | - | - | |
UBS Europ Fin Debt Sust EUR U-X Acc | LU2520351177 | 0.94 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | BUY | BUY |
Summary | Strong Buy | Buy | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review